共 50 条
- [1] Conformal re-irradiation of recurrent and new primary head-and-neck cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (02): : 377 - 385
- [2] Stereotactic Re-irradiation for Recurrent or Second Primary Head-and-Neck Cancer [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2018, 33 (01): : 38 - 41
- [3] Phase 1 Clinical Trial of Re-irradiation With Pemetrexed and Erlotinib Followed by Maintenance Erlotinib for Patients With Recurrent and Second Primary Squamous Cell Carcinoma of the Head and Neck Management of Recurrent Head-and-Neck Squamous Cell Carcinoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 508 - 508
- [4] Re-irradiation with IMRT for head and neck cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S454 - S455
- [6] The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer [J]. Radiation Oncology, 15
- [8] Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC) Management of Recurrent Head-and-Neck Squamous Cell Carcinoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 507 - 507